Want to see KR:200130 full AI Analyst Report?
Top Page
KolmarBNH Co., Ltd.
(200130)
Select Model
Select Model
Rating:50Neutral
Price Target:
$7,220.00
Action:N/A
Date:10/28/26
The score is held back primarily by deteriorating profitability (2025 net loss and lower revenue) and a clearly bearish trend across moving averages with negative MACD. These are partly offset by improved cash generation (free cash flow turning positive) and a balance sheet that remains moderately levered, but valuation support is limited given the negative P/E and only modest dividend yield.
Positive Factors
ODM/OEM Business Model
KolmarBNH’s ODM/OEM model combines product formulation, development, and manufacturing for client brands, creating an integrated service offering. Supporting multiple supplement formats and customer requirements can deepen commercial relationships and provide a durable platform for recurring outsourced production demand.
Negative Factors
Revenue and Profitability Decline
The combination of lower revenue and a return to net losses shows that recent earnings power has weakened materially from 2023–2024. Stable gross margin has not prevented overall profitability deterioration, reducing internal funding capacity and making future earnings less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
ODM/OEM Business Model
KolmarBNH’s ODM/OEM model combines product formulation, development, and manufacturing for client brands, creating an integrated service offering. Supporting multiple supplement formats and customer requirements can deepen commercial relationships and provide a durable platform for recurring outsourced production demand.
Read all positive factors
KolmarBNH Co., Ltd. (200130) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩204.92B
Dividend Yield0.77%
Average Volume (3M)30.87K
Price to Earnings (P/E)―
Beta (1Y)0.32
Revenue Growth-8.83%
EPS Growth-111.22%
CountryKR
EmployeesN/A
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-69.01
Shares Outstanding28,775,558
10 Day Avg. Volume35,766
30 Day Avg. Volume30,873
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.23
Price to Sales (P/S)0.76
P/FCF Ratio27.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)910.3
Revenue Forecast (FY)₩713.40B
KolmarBNH Co., Ltd. Business Overview & Revenue Model
Company Description
Kolmar BNH Co Ltd is a South Korean enterprise specializing in the production and supply of diverse pharmaceutical products, such as medicinal compounds, antibiotics, and biologics. Beyond its pharmaceutical core, the company also develops health-...
KolmarBNH Co., Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
58
Neutral
Cash Flow
64
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 575.05B | 574.88B | 615.64B | 579.55B | 575.90B | 593.08B |
| Gross Profit | 86.34B | 83.04B | 85.06B | 81.00B | 103.02B | 130.25B |
| EBITDA | 16.56B | 2.69B | 51.41B | 49.88B | 73.54B | 105.30B |
| Net Income | -1.77B | -22.67B | 18.05B | 19.71B | 40.51B | 69.87B |
Balance Sheet | ||||||
| Total Assets | 593.58B | 649.69B | 690.87B | 694.51B | 616.92B | 537.89B |
| Cash, Cash Equivalents and Short-Term Investments | 121.74B | 110.51B | 110.65B | 86.78B | 107.02B | 171.81B |
| Total Debt | 150.36B | 215.48B | 224.88B | 208.12B | 153.43B | 69.59B |
| Total Liabilities | 216.24B | 294.21B | 295.60B | 298.21B | 214.23B | 151.25B |
| Stockholders Equity | 375.72B | 353.77B | 397.09B | 398.69B | 401.61B | 385.53B |
Cash Flow | ||||||
| Free Cash Flow | 27.21B | 15.58B | -9.22B | -36.04B | -44.32B | 23.71B |
| Operating Cash Flow | 47.28B | 37.90B | 39.20B | 56.28B | 5.33B | 71.94B |
| Investing Cash Flow | 60.46B | 22.80B | -42.36B | -96.91B | -72.61B | -93.98B |
| Financing Cash Flow | -46.33B | -16.89B | -9.17B | 32.85B | 34.28B | 12.61B |
KolmarBNH Co., Ltd. Technical Analysis
Negative
―
Price Trends
8203.96
Negative
8403.84
Negative
10265.99
Negative
Market Momentum
-188.23
Positive
41.29
Neutral
26.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:200130, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 7748.00, equal to the 50-day MA of 8203.96, and equal to the 200-day MA of 10265.99, indicating a bearish trend. The MACD of -188.23 indicates Positive momentum. The RSI at 41.29 is Neutral, neither overbought nor oversold. The STOCH value of 26.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:200130.
KolmarBNH Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₩237.94B | 9.95 | ― | 4.78% | -7.25% | 63.69% | |
65 Neutral | ₩209.73B | 3.78 | ― | 3.55% | 25.12% | 295.70% | |
64 Neutral | ₩291.52B | 6.23 | ― | 3.18% | -8.00% | -1.42% | |
60 Neutral | ₩2.80T | 14.58 | ― | 1.34% | 15.81% | 197.32% | |
56 Neutral | ₩2.66T | 14.36 | ― | 0.77% | 12.57% | 90.44% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | ₩204.92B | -243.15 | ― | 0.77% | -8.83% | -111.22% |
* General Sector Average
KR:200130
KolmarBNH Co., Ltd.
7,410.00
-6,179.50
-45.47%
KR:024720
KOLMAR HOLDINGS CO. LTD.
8,500.00
-2,222.20
-20.73%
KR:044820
Cosmax BTI Inc.
21,950.00
8,814.86
67.11%
KR:078520
Able C&C Co Ltd
9,640.00
128.85
1.35%
KR:161890
KOLMAR KOREA CO. LTD
112,500.00
37,423.84
49.85%
KR:192820
COSMAX, Inc.
247,000.00
48,251.70
24.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.